Clinical Trial Update: Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In Children [Phase 3]

View source ↗

Summary

Phase 3 trial update on the efficacy and safety of Dysport for upper limb spasticity in children has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Limb Spasticity in Children

Drugs mentioned

• Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Upper Limb Spasticity (Altered Skeletal Muscle Performance) in Children | Phase 3 | Status: COMPLETED | Results posted: 2019-12-24